Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Albendazole

An anthelmintic of the benzimidazole family, synthesised in 1972 and approved for human use in the early 1980s: it is a mainstay treatment against intestinal worms, including in WHO-backed deworming programmes. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?It was born in veterinary research: chemist Robert Gyurik synthesised it on his own initiative in about two months, and its first efficacy test was carried out in sheep.

AlbendazoleGo to the active ingredient →
AlbendazoleActive ingredientAlbendazoleCat. No. P-A062-001CAS 54965-21-8
Albendazole-d7Isotopically labelledAlbendazole-d7Cat. No. P-A062-017CAS 1287076-43-0

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.